| Mr Larry Alan Vaughn, MD | |
|
705 Dixie St, Carrollton, GA 30117-3818 | |
| (770) 838-8929 | |
| (770) 838-8930 |
| Full Name | Mr Larry Alan Vaughn |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 705 Dixie St, Carrollton, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306929864 | NPI | - | NPPES |
| 000374195E | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 029812 (Georgia) | Secondary |
| 208M00000X | Hospitalist | 029812 (Georgia) | Primary |
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20060419000545 |
News Archive
The Davis Phinney Foundation, a non-profit organization dedicated to improving the lives of people with Parkinson's disease (PD) today, announced that it has awarded four Parkinson's disease research centers with support to conduct a landmark study on the long-term changes in quality of life and mobility that occur in people with PD. The results of this research will help to advance the understanding of how interventions, such as exercise, impact changes in quality of life and mobility over the course of the disease.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December 31, 2014.
Mental illnesses, such as major depression, bipolar disorder and post-traumatic stress disorder, affect nearly 1 in 5 adults in the United States, according to the National Alliance on Mental Illness. Many aspects of these illnesses remain something of a mystery, despite the progress made in understanding them by researchers studying these disorders in the last half century.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Larry Alan Vaughn, MD 705 Dixie St, Carrollton, GA 30117-3818 Ph: (770) 838-8929 | Mr Larry Alan Vaughn, MD 705 Dixie St, Carrollton, GA 30117-3818 Ph: (770) 838-8929 |
News Archive
The Davis Phinney Foundation, a non-profit organization dedicated to improving the lives of people with Parkinson's disease (PD) today, announced that it has awarded four Parkinson's disease research centers with support to conduct a landmark study on the long-term changes in quality of life and mobility that occur in people with PD. The results of this research will help to advance the understanding of how interventions, such as exercise, impact changes in quality of life and mobility over the course of the disease.
China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December 31, 2014.
Mental illnesses, such as major depression, bipolar disorder and post-traumatic stress disorder, affect nearly 1 in 5 adults in the United States, according to the National Alliance on Mental Illness. Many aspects of these illnesses remain something of a mystery, despite the progress made in understanding them by researchers studying these disorders in the last half century.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
› Verified 2 days ago
Steven Allen Eubanks Jr., M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 148 Clinic Ave, Carrollton, GA 30117 Phone: 770-838-8640 Fax: 770-838-8650 | |
Vaughn S Clagette, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 705 Dixie St, Carrollton, GA 30117 Phone: 770-838-8929 Fax: 770-838-8930 | |
Dr. Suzanne Cahill Manley, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 148 Clinic Ave, Carrollton, GA 30117 Phone: 770-838-8640 Fax: 770-838-8650 | |
Dr. Holley Elizabeth Beam, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 148 Clinic Ave, Carrollton, GA 30117 Phone: 770-838-8640 Fax: 770-838-8650 |